Downloads provided by UsageCounts
AMYPAD encourage the publication of any research arising from the AMYPAD Prognostic and Natural History Study (PNHS). If you publish results that were generated using the AMYPAD PNHS data, it is mandatory to acknowledge the AMYPAD Consortium and the grants that supported this IMI project. More details are provided in this document, which outlines the policies for publication and the publication credits for those who use the AMYPAD PNHS data.
AMYPAD PNHS is registered at www.clinicaltrialsregister.eu with the EudraCT Number: 2018-002277-22. The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. This Joint Undertaking received support from the European Union's Horizon 2020 research and innovation programme and EFPIA.
Cognition, AMYPAD, Dementia, Neuroimaging, Alzheimer's disease, Biomarkers
Cognition, AMYPAD, Dementia, Neuroimaging, Alzheimer's disease, Biomarkers
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 99 | |
| downloads | 42 |

Views provided by UsageCounts
Downloads provided by UsageCounts